Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Enzyme inactivation by chemical treatment
Reexamination Certificate
2006-03-21
2006-03-21
Campell, Bruce R. (Department: 1654)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Enzyme inactivation by chemical treatment
C514S836000
Reexamination Certificate
active
07015021
ABSTRACT:
The present disclosure relates to a single step method for purifying PAI-1, PAI-1 fragments and PAI-1 mutants using a metal chelate resin. The disclosure further relates to the purified PAI-1 obtained by the disclosed method and uses for the purified PAI-1.
REFERENCES:
patent: 5866413 (1999-02-01), Sambrook et al.
patent: 6103498 (2000-08-01), Lawrence et al.
Arroya De Prada N, Schroeck F, Sinner EK, Muehlenweg B, Twellmeyer J, Sperl S, Wilhelm OG, Schmitt M, Magdolen V (2002). Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.Eur J Biochem269(1):184-192.
Muehlenweg B, Sperl S, Magdolen V, Schmitt M, Harbeck N (2001). Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumors.Expert Opin. Biol. Ther.4:683-691.
Berkenpas MB, Lawrence DA, Ginsberg D (1995). Molecular evolution of plasminogen activator inhibitor-1 functional stability.EMBO J14(13):2969-2977.
Lawrence DA, Ginsburg D (1995). Plasminogen Activator Inhibitors. In: Molecular Biology of Thrombosis and Hemostasis, Roberts HR et al., (Eds.), Marcel Dekker Inc., New York, Chapter 25, pp. 517-543.
Lawrence DA, Olson ST, Palaniappan S, Ginsburg D (1994). Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.Biochemistry33(12):3643-3648.
Angles-Cano E, Gris JC, Loyau S, Schved JF (1993). Familial association of high levels of histidine-rich glycoprotein and plasminogen activator inhibitor-1 with venous thromboembolism.J Lab Clin Med121(5):646-653.
Kassis J, Hirsh J, Podor TJ (1992). Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell I plasminogen activator inhibitor biosynthesis.Blood80(7):1758-1764.
Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Shen C, Newcomer LM, Goldhaber SZ, Hennekens CH (1992). Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.Circulation85(5):1822-1827.
Sherman PM, Lawrence DA, Yang AY, Vandenberg ET, Paielli D, Olson ST, Shore JD, Ginsburg D (1992). Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center.J. Biol. Chem.267(11):7588-7595.
Ellis V, Dano K (1991). Plasminogen activation by receptor-bound urokinase.Semin Thromb Hemost17(3):194-200.
Plow EF, Felez J, Miles LA (1991). Cellular regulation of fibrinolysis.Thromb Haemost66(1):32-36.
Pollanen J, Stephens RW, Vaheri A (1991). Directed plasminogen activation at the surface of normal and malignant cells.Adv Cancer Res57:273-328.
Erickson LA, Fici GJ, Lund JE, Boyle TP, Polites HG, Marotti KR (1990). Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene.Nature346(6279):74-76.
Hajjar KA, Hamel NM (1990). Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. JBiol Chem265(5):2908-2916.
Reilly TM, Seetharam R, Duke JL, Davis GL, Pierce SK, Walton HL, Kingsley D, Sisk WP (1990). Purification and characterization of recombinant plasminogen activator inhibitor-1 fromEscherichia coli. J Bio Chem265(16):9570-9574.
Lawrence D, Strandberg L, Grundstrom T, Ny T (1989). Purification of active human plasminogen activator inhibitor 1 fromEscherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.Eur J Biochem186(3):523-533.
Lindahl T, Wiman B (1989). Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.Biochim Biophys Acta994(3):253-257.
Wun TC, Palmier MO, Siegel NR, Smith CE (1989). Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.J Biol Chem264(14):7862-7868.
Alessi MC, Declerck PJ, De Mol M, Nelles L, Collen D (1988). Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).Eur. J. Biochem175(3):531-540.
Aznar J, Estelles A, Tormo G, Sapena P, Tormo V, Blanch S, Espana F (1988). Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.Br Heart J59(5):535-541.
Hsueh AJW, Liu YX, Cajander SB, Ny T (1988). Molecular mechanisms in the hormonal regulation of plasminogen activator activity in ovarian granulosa cells and cumulus-oocyte complexes. In: Haseltine FP et al, eds, “Meiotic Inhibition: Molecular Control of Meiosis.” New York: Liss, pp. 227-258.
Moscatelli D, Rifkin MR (1988). Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.Biochim Biophys Acta948(1):67-85.
Saksela O, Rifkin DB (1988). Cell-associated plasminogen activation: regulation and physiological functions.Annu Rev Cell Biol4:93-126.
Hekman CM, Loskutoff DJ (1988). Bovine plasminogen activator inhibitor 1: specificity determinations and comparison of the active, latent, and guanidine-activated forms.Biochemistry27(8):2911-2918.
Levin EG, Santell L (1987). Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells.Blood70(4):1090-1098.
Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985). Plasminogen activators, tissue degradation, and cancer.Adv Cancer Res44:139-266.
Hamsten A, Wiman B, de Faire U, Blomback M (1985). Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.N Engl J Med313(25):1557-1563.
Hekman CM, Loskutoff DJ (1985). Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.J Biol Chem260(21):11581-11587.
Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO (1985). The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma.Scand J Clin Lab Invest45(7):605-610.
Nilsson IM, Ljungner H, Tengborn L (1985). Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.Br Med J290(6480):1453-1456.
Paramo JA, Colucci M, Collen D, van de Werf F (1985). Plasminogen activator inhibitor in the blood of patients with coronary artery disease.Br Med J291(6495):573-574.
Saksela O (1985). Plasminogen activation and regulation of pericellular proteolysis.Biochim Biophys Acta823(1):35-65.
Wiman B, Ljungberg B, Chmielewska J, Urden G, Blomback M, Johnsson H (1985). The role of the fibrinolytic system in deep vein thrombosis.J Lab Clin Med105(2):265-270.
Juhan-Vague I, Moerman B, De Cock F, Aillaud MF, Collen D (1984). Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditions.Thromb Res33(5):523-530.
van Mourik JA, Lawrence DA, Loskutoff DJ (1984). Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.J Biol Chem259(23):14914-14921.
Hoylaerts M, Rijken DC, Lijnen HR, Collen D (1982). Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.J Biol Chem257(6):2912-2919.
Campell Bruce R.
Chism B. Dell
Fitzpatrick ,Cella, Harper & Scinto
Molecular Innovations, Inc.
LandOfFree
Method for making purified plasminogen activator-inhibitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for making purified plasminogen activator-inhibitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for making purified plasminogen activator-inhibitor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3537982